The effect of Pap smear screening on cervical cancer stage among southern Thai women

Niu, Li; Virani, Shama; Bilheem, Surichai; Sriplung, Hutcha

doi:10.1038/s41598-019-52607-6

Cited by 13 publications

(12 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, Muslim women were more likely to get preventable female cancers than non-Muslim women, and were more likely to be detected at an advanced stage (Namoos et al, 2021). This finding corresponded to a study in a different location, which discovered that Muslim women had nearly twice the likelihood of being diagnosed late when compared to women of other religions (Niu et al, 2019).…”

Section: Introductionsupporting

confidence: 68%

“…Towards achieving this, the World Health Organization (WHO) urges all nations to scale up all levels of disease prevention efforts, including screening and treatment of cervical cancers, for eligible populations (Organization, 2020). Women who get examined regularly have a better probability of early detection and are less likely to be detected at an advanced stage, thus reducing cervical cancer's morbidity and mortality (Loud and Murphy, 2017;Niu et al, 2019). The critical discovery that cervical cancer is caused by recurrent oncogenic Human Papillomavirus (HPV) infections has prompted a significant change in cervical cancer screening and prevention approaches (Schiffman et al, 2007;Cohen et al, 2019).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review

Amir

Idris

Yusoff

2022

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

Introduction: Human Papillomavirus (HPV) self-sampling test has the potential to increase cervical cancer screening rate. Although every screening test has its own advantages and disadvantages, culture and religion can be significant predictors for the acceptability of screening tests among patients, including the HPV self-sampling test. This systematic review intends to identify and review published literature on the acceptance of HPV self-sampling test among Muslim women globally. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) review protocol was utilised to guide this systematic review. We also used the Mixed Method Appraisal Tool (MMAT) for the evaluation of articles, and data from selected papers were retrieved and analysed using thematic analysis. Results: This systematic review includes seven publications that discussed on Muslim women’s perceptions of HPV self-sampling test. This comprises articles that revealed Muslim women’s acceptance of the HPV self-sampling test, including considerable positive factors that influenced their approval. On the other hand, the test’s disadvantages were mentioned, which served as barriers for these women’s participation. Convenience, cultural sensitivity, and availability were positive features, whereas religious taboo, low self-confidence, and perceived cost were some of the negative factors that were discussed. Conclusion: This review emphasises the positive and negative aspects that have an impact on the acceptance of HPV self-sampling test among Muslim women. Identifying the elements that influence HPV self-sampling test acceptance will help policymakers to better understand cervical cancer screening programmes and further guide future plans in reducing the incidence of cervical cancer.

show abstract

Section: Introductionsupporting

confidence: 68%

Section: Introductionmentioning

confidence: 99%

The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review

Amir

Idris

Yusoff

2022

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

show abstract

“…Despite the national maximum effort for cervical cancer screening campaigns and health education, cervical smear coverage was only 46.3% in 2007 and had slightly increased to 59.7% in 2009 12 . The rate of screening for cervical cancer was not optimal among several groups of women, namely those who were less‐educated, poor, young, unmarried, and non‐Buddhist 13 …”

Section: The Past Present and Future Of The Prevention Of Cervical mentioning

confidence: 99%

Experiences in the prevention and screening of cervical cancer within Thailand

Kengsakul

Laowahutanont

Wilailak

2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Cervical cancer is the third most common cancer among Thai women, after breast and colon cancer, with an age-standardized incidence rate (ASR) of 11.7/100 000 women each year, as of 2015. Over decades, comprehensive national cervical cancer screening programs, research, and the HPV vaccination policy have gradually helped decrease the incidence of cervical cancer in Thailand. In 2017, the Thai Ministry of Public Health signed a memorandum of understanding with the Royal Thai College of Obstetricians and Gynecologists to eliminate invasive cervical cancer from Thailand. This is a tremendous challenge for Thailand as a whole. The present paper reviews and discusses the experiences in the prevention and screening of cervical cancer in Thailand.

show abstract

“…Cervical cancer is a cancer of the cells located in the cervix [3]. It is the third most common cancer in women globally and is mainly caused by the sexual transmission of the human papillomavirus (HPV) [2][3][4][5][6]. The location of the cervix makes it easily accessible through the vagina and allows for a non-invasive localised delivery of chemotherapeutic drugs; adjacent to the cancerous tissue either before resection (neoadjuvant therapy), to reduce tumour size, or after resection (adjuvant therapy) to reduce the risk of recurrence [7].…”

Section: Introductionmentioning

confidence: 99%

A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix

et al. 2020

View full text Add to dashboard Cite

This study was performed to develop an adjuvant therapy in the form of a self-administered vaginal tablet regimen for the localized delivery of chemotherapeutic drugs. This therapy will help to reduce relapse by eradicating cancerous cells in the margin of cervical tumors. The vaginal tablet is a very common formulation that is easy to manufacture, easy to place in the vagina, and has a low cost of manufacture, making them ideal for use in developing countries. A combination of disulfiram and 5-fluorouracil, which are both off-patent drugs and provide different modes of action, were evaluated. The tablets developed were evaluated for weight variation, thickness, hardness, friability, swelling index, differential scanning calorimetry (DSC), particle morphology, in vitro drug release, and cytotoxicity on Ca-Ski cells. Both layers were designed to release both drugs concurrently for a synergistic effect. The polymer–polymer interaction between the layers was able to reduce the loss of formulation due to chitosan. While the bilayer tablet had satisfactory performance in the physicochemical tests, in vitro cell culture with Ca-Ski also showed a synergistic effect using a combination of drugs at a low dose. However, the formulation only had 24-h dose release before degradation. Further drug combinations should be evaluated in subsequent studies.

show abstract

The effect of Pap smear screening on cervical cancer stage among southern Thai women

Cited by 13 publications

References 16 publications

The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review

The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review

Experiences in the prevention and screening of cervical cancer within Thailand

A Bilayer Vaginal Tablet for the Localized Delivery of Disulfiram and 5-Fluorouracil to the Cervix

Contact Info

Product

Resources

About